Sylvie Doulut

426 total citations
9 papers, 376 citations indexed

About

Sylvie Doulut is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Microbiology. According to data from OpenAlex, Sylvie Doulut has authored 9 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 2 papers in Microbiology. Recurrent topics in Sylvie Doulut's work include Neuropeptides and Animal Physiology (6 papers), Chemical Synthesis and Analysis (4 papers) and Antimicrobial Peptides and Activities (2 papers). Sylvie Doulut is often cited by papers focused on Neuropeptides and Animal Physiology (6 papers), Chemical Synthesis and Analysis (4 papers) and Antimicrobial Peptides and Activities (2 papers). Sylvie Doulut collaborates with scholars based in France and Canada. Sylvie Doulut's co-authors include Jean Martínez, Marc Rodriguez, Annie Heitz, Patrick Kitabgi, Isabelle Dubuc, André Aumelas, Jean Costentin, William Rostène, Catherine Labbé‐Jullié and Jean Mazella and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Sylvie Doulut

9 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Doulut France 8 274 194 103 46 46 9 376
Vittorio Pestellini Italy 11 270 1.0× 227 1.2× 191 1.9× 22 0.5× 9 0.2× 36 485
Miklós Löw Hungary 10 266 1.0× 123 0.6× 107 1.0× 29 0.6× 23 0.5× 14 337
Antoinette Viger France 11 285 1.0× 238 1.2× 32 0.3× 16 0.3× 16 0.3× 21 408
Michael Higginbottom United Kingdom 10 248 0.9× 190 1.0× 75 0.7× 72 1.6× 3 0.1× 14 349
Jean‐Claude Galleyrand France 11 196 0.7× 134 0.7× 27 0.3× 44 1.0× 8 0.2× 18 398
Cristina Bellucci Italy 14 308 1.1× 110 0.6× 209 2.0× 50 1.1× 13 0.3× 41 516
Giles S. Ratcliffe United Kingdom 15 349 1.3× 139 0.7× 209 2.0× 47 1.0× 3 0.1× 24 501
Paul Hershberger United States 13 237 0.9× 136 0.7× 101 1.0× 29 0.6× 7 0.2× 20 397
Katsuyoshi Nakajima Japan 12 228 0.8× 40 0.2× 65 0.6× 35 0.8× 3 0.1× 37 420
Jonathan C. O’Connell United States 13 489 1.8× 194 1.0× 65 0.6× 35 0.8× 4 0.1× 18 585

Countries citing papers authored by Sylvie Doulut

Since Specialization
Citations

This map shows the geographic impact of Sylvie Doulut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Doulut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Doulut more than expected).

Fields of papers citing papers by Sylvie Doulut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Doulut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Doulut. The network helps show where Sylvie Doulut may publish in the future.

Co-authorship network of co-authors of Sylvie Doulut

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Doulut. A scholar is included among the top collaborators of Sylvie Doulut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Doulut. Sylvie Doulut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Labbé‐Jullié, Catherine, Isabelle Dubuc, Aline Brouard, et al.. (1994). In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.. Journal of Pharmacology and Experimental Therapeutics. 268(1). 328–336. 67 indexed citations
2.
Doulut, Sylvie, Isabelle Dubuc, H. Fulcrand, et al.. (1993). Synthesis and analgesic effects of N-[3-[(hydroxyamino)carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymes. Journal of Medicinal Chemistry. 36(10). 1369–1379. 32 indexed citations
3.
Kitabgi, Patrick, Catherine Labbé‐Jullié, Isabelle Dubuc, et al.. (1992). FUNCTIONAL AND PHARMACOLOGICAL ASPECTS OF CENTRAL NEUROPEPTIDERGIC TRANSMISSION MEDIATED BY NEUROTENSIN AND NEUROMEDIN N. Clinical Neuropharmacology. 15. 313A–314A. 15 indexed citations
4.
Dubuc, Isabelle, et al.. (1992). JMV 449: A pseudopeptide analogue of neurotensin-(8–13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse. European Journal of Pharmacology. 219(2). 327–329. 32 indexed citations
5.
Doulut, Sylvie, et al.. (1992). SiO2 removal from water by strong-base anion-exchange resins. Reactive Polymers. 17(1). 15–20. 5 indexed citations
6.
Aubagnac, J.‐L., et al.. (1992). Dehydroxylation reaction induced by the matrix in the fast atom bombardment mass spectra of a peptide. Organic Mass Spectrometry. 27(5). 645–647. 10 indexed citations
7.
Doulut, Sylvie, et al.. (1992). Reduced peptide bond pseudopeptide analogues of neurotensin.. PubMed. 5(1). 30–8. 31 indexed citations
8.
Doulut, Sylvie, et al.. (1991). Reduced peptide bond pseaadopeptide analogues of neurotensins binding and biological activities, and in vitro metabolic stability. European Journal of Pharmacology. 205(2). 191–198. 57 indexed citations
9.
Rodriguez, Marc, et al.. (1991). A facile synthesis of chiral N-protected β-amino alcohols.. Tetrahedron Letters. 32(7). 923–926. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026